Single-Step Maternal Serum Screening for Trisomy 21 in the Era of Combined or Integrated Screening

Publisher： Karger

E-ISSN： 1423-002x|58|4|221-224

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.58, Iss.4, 2004-11, pp. : 221-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of the Maternal Age-Related Risk in First-Trimester Combined Screening for Trisomy 21

By  

Fetal Diagnosis and Therapy, Vol. 30, Iss. 2, 2011-06 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency and Maternal Serum Biochemistry at 11–14 Weeks: A Regional Experience from Germany

By  

Fetal Diagnosis and Therapy, Vol. 21, Iss. 3, 2006-04 ,pp. : 264-268

Karger

Access to resources Recommend Favorite

Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11–13 Weeks?

By  

Fetal Diagnosis and Therapy, Vol. 30, Iss. 1, 2011-03 ,pp. : 53-59

Karger

Access to resources Recommend Favorite

Parental Decisions about Prenatal Screening and Diagnosis among Infants with Trisomy 21 in a National Cohort with High Uptake of Combined First-Trimester Screening

By  

Fetal Diagnosis and Therapy, Vol. 41, Iss. 3, 2016-07 ,pp. : 209-214

Karger

Access to resources Recommend Favorite

Interest of Foetal Nasal Bone Measurement at First Trimester Trisomy 21 Screening

By  

Fetal Diagnosis and Therapy, Vol. 21, Iss. 5, 2006-08 ,pp. : 433-438

Karger

Access to resources Recommend Favorite